Roche Holding AG stock trades on the US exchange. Find market mover at RealPennies.com
Stock Overview: Roche Holding AG
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.
More Company Details
Latest News Roche Holding AG
Regeneron Eye Drug's Advantage Over Roche's Narrowed in Trial.
Feb 27, 2016
Odd Lots Podcast: Lorcan Roche Kelly.
Feb 16, 2016
Europe Stocks Snap 2-Day Gain as Roche, H&M Earnings Disappoint.
Jan 28, 2016
Roche Falls After Full-Year Profit Misses Analyst Estimates.
Jan 28, 2016
Cancer Therapy Promise Makes Roche the Darling of Drug Stocks.
Jan 12, 2016
VEA: Vanguard MSCI EAFE ETF.
Dec 26, 2015
Roche Discount Fails to Win Breast-Cancer Drug U.K. Backing.
Dec 16, 2015
Europe Shares Rebound From Worst Week Since August; Roche Gains.
Dec 07, 2015
Roche Plans to Exit Four Sites, Cut Jobs at Cost of $1.6 Billion.
Nov 12, 2015
Stocks Rally as Oil Inventories Fall Faster Than Expected.
Roche Holdings, Ltd., a biotech company, operates in the fields of pharmaceuticals and diagnostics worldwide. It offers products and services for the early detection, prevention, diagnosis, and treatment of various diseases. The company offers in-vitro diagnostics and drugs for cancer and transplantation, cardiovascular and dermatological diseases, and virology. It also offers products for other therapeutic areas, such as autoimmune diseases, inflammatory and metabolic disorders, and diseases of the central nervous system. In addition, Roche Holdings provides a range of products and services in various fields of medical testing. It provides solutions for medical and biotechnological research...
RealPennies is not a registered investment advisor, quotes are delayed.
We track all penny stocks in the OTC, OTCBB & PinkSheet Markets.